Biocryst Pharmaceuticals (BCRX) Exchange Rate Effect (2021 - 2026)
Biocryst Pharmaceuticals (BCRX) reported Exchange Rate Effect of -$72000.0 for Q1 2026, down 115.96% on a YoY basis from $451000.0 in Q1 2025, and little changed quarter-over-quarter from -$72000.0 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Biocryst Pharmaceuticals has reported Exchange Rate Effect for 6 years, with the latest figure at -$72000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 115.96% year-over-year to -$72000.0; the trailing twelve-month figure through Mar 2026 stood at $747000.0 (up 615.17% YoY), and the FY2025 full-year result was $1.3 million, up 235.68% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$72000.0, roughly flat from -$72000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.4 million in Q2 2025, with the low at -$1.3 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged $70000.0 across 5 years, with a median of -$14000.0 in 2022.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect jumped 16450.0% — and 2024, when it sank 349.81%.
- Biocryst Pharmaceuticals' Exchange Rate Effect stood at $331000.0 in 2022, then surged by 57.7% to $522000.0 in 2023, then sank by 349.81% to -$1.3 million in 2024, then surged by 94.48% to -$72000.0 in 2025, then changed by 0.0% to -$72000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$72000.0 (Q1 2026), -$72000.0 (Q4 2025), and -$468000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2.38 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -22,000.00 |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 1.78 Bn | 151.04 Mn | -72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72,000.00 |
| Mar 31, 2026 | -72,000.00 |
| Dec 31, 2025 | -72,000.00 |
| Dec 31, 2025 | -72,000.00 |
| Sep 30, 2025 | -468,000.00 |
| Sep 30, 2025 | -468,000.00 |
| Jun 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 451,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Dec 31, 2024 | -1.30 Mn |
| Dec 31, 2024 | -1.30 Mn |
| Sep 30, 2024 | 851,000.00 |
| Sep 30, 2024 | 851,000.00 |
| Jun 30, 2024 | -143,000.00 |
| Jun 30, 2024 | -143,000.00 |
| Mar 31, 2024 | -340,000.00 |
| Mar 31, 2024 | -340,000.00 |
| Dec 31, 2023 | 522,000.00 |
| Dec 31, 2023 | 522,000.00 |